ArticleCancer2026

Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.

Tae Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.